while early this is possibly a longer term head wind for BD1. It is not and could not be for years after our commercial release (s)
Blood test 'can check for more than 50 types of cancer' A BIG Point not making it not really a issue for BD1 is "Trial data suggests it is better at detecting more advanced disease rather than the beginnings of cancer, which may limit how useful it becomes. "
FYI only DYRO and keep safe all
Chart, page-612
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
-0.010(1.75%) |
Mkt cap ! $59.09M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 57.0¢ | 54.0¢ | $96.73K | 176.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12 | 55.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.0¢ | 7999 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |